Clearance Summary
AMPLAID MARK 4 AND MARK 5 received FDA 510(k) clearance under submission number K781667, sponsored by Amplaid USA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 1978-11-03.
- Submission: K781667
- Applicant / Sponsor: Amplaid USA, Inc.
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1900
- Decision date: 1978-11-03
Classification & Regulation
This clearance is catalogued under FDA product code GWJ and 21 CFR 882.1900, within the Neurology review panel as a Class II device.